top of page
ื•ื•ืื˜ืกืืค ืœื•ื— ื“ืจื•ืฉื™ื
ืคื™ื™ืกื‘ื•ืง D-HR
ืื™ื ืกื˜ื’ืจื D-HR
ืœื™ื ืงื“ืื™ืŸ D-HR

ืžืฉืจื•ืช ืžื›ืฉื•ืจ ืจืคื•ืื™

Medical Device

ื ืฆื™ื’.ืช ืžื›ื™ืจื•ืช ื‘ืชื—ื•ื ืžืขื‘ื“ื•ืช

ืžืจื›ื–, ืฉืจื•ืŸ, ืฉืคืœื”

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-882

ืชืขืžื•ืœื” ื•ืžื›ื™ืจื•ืช ืžื•ืฆืจื™ ื—ื‘ื™ืฉื” ืื–ื•ืจ ืฉืจื•ืŸ-ืฆืคื•ืŸ

ืฉืจื•ืŸ, ืฆืคื•ืŸ

ืื™ื–ื•ืจ:

ื”ื™ืงืฃ:

JB-881

ืื™ืฉ/ืช ืžื›ื™ืจื•ืช ืœืชื—ื•ื ื”ืงืคื™ื˜ืœื™

ื“ืจื•ื, ื›ืœ ื”ืืจืฅ, ืžืจื›ื–, ืฆืคื•ืŸ, ืฉืคืœื”, ืฉืจื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-817

ืžื ื›"ืœ.ื™ืช ืขื‘ื•ืจ ื—ื‘ืจืช ืกื˜ืืจื˜ ืืค ื‘ืชื—ื•ื ื”ื“ื™ืื’ื ื•ืกื˜ื™ืงื”

ืžืจื›ื–, ืฉืจื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-855

ืื™ืฉ.ืช ืชืžื™ื›ื” ืงืœื™ื ื™ืช ื•ืžื›ื™ืจื•ืช ื‘ืชื—ื•ื ื”ืขื™ื ื™ื™ื
ืžืจื›ื– ื™ืจื•ืฉืœื™ื ื•ืฉืคืœื”

ืฉืคืœื”, ืžืจื›ื–

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-751

ืื™ืฉ.ืช ืžื›ื™ืจื•ืช ืžื›ืฉื•ืจ ืจืคื•ืื™-ืื–ื•ืจ ืžืจื›ื– ื“ืจื•ื ื•ื™ืจื•ืฉืœื™ื

ืžืจื›ื–, ื“ืจื•ื, ืฉืคืœื”

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-767

ืื™ืฉ/ืช ืžื›ื™ืจื•ืช ืœื—ื˜ื™ื‘ืช ืžื›ืฉื•ืจ ื›ื™ืจื•ืจื’ื™ื” ืื™ื–ื•ืจ ื™ืจื•ืฉืœื™ื ืฉืคืœื” ื•ื”ื“ืจื•ื

ืฉืคืœื”, ืžืจื›ื–, ื“ืจื•ื

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-809

ืžื•ืžื—ื”.ื™ืช ืืคืœื™ืงืฆื™ื” ืœื—ื‘ืจืช ืฆื™ื•ื“ ืœืžืขื‘ื“ื•ืช

ืฆืคื•ืŸ, ืฉืจื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-779

ืื™ืฉ/ืช ืžื›ื™ืจื•ืช ื‘ืชื—ื•ื ื“ื™ืžื•ืช ื•ืจื“ื™ื•ืœื•ื’ื™ื” ืคื•ืœืฉื ื™ืช

ืžืจื›ื–, ืฉืจื•ืŸ, ืฉืคืœื”, ื›ืœ ื”ืืจืฅ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-765

CRA (Clinical Research Associate)

ืฉืคืœื”

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-759

ืžืฉื ื” ืœืžื ื›"ืœ

ืฉืคืœื”

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-752

ืžื”ื ื“ืก.ืช ืฉื™ืจื•ืช ืœืžืขืจื›ืช ืœื ื™ื”ื•ืœ ืžื™ื“ืข ื‘ืžืขื‘ื“ื” ืจืคื•ืื™ืช.

ืžืจื›ื–

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-746

ืžื”ื ื“ืก. ืื™ื›ื•ืช ืœื—ื‘ืจืช ืžื›ืฉื•ืจ ืจืคื•ืื™ ื‘ืงื™ืกืจื™ื”

ืฆืคื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-729

ืžื”ื ื“ืก.ืช ืฉื™ืจื•ืช ืชื—ื•ื ืžื›ืฉื•ืจ ืจืคื•ืื™ ืžืขื‘ื“ืชื™

ืžืจื›ื–, ืฉืจื•ืŸ, ืฆืคื•ืŸ, ื›ืœ ื”ืืจืฅ, ื“ืจื•ื, ืฉืคืœื”

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-725

ืื™ืฉ/ืช ืžื›ื™ืจื•ืช ืœื—ื˜ื™ื‘ืช ืžื›ืฉื•ืจ ื›ืจื•ืจื’ื™ื” ืื™ื–ื•ืจ ืฆืคื•ืŸ

ืฆืคื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-719

ืื™ืฉ/ืช ืžื›ื™ืจื•ืช ืžื›ืฉื•ืจ ื•ืฆื™ื•ื“ ืขื™ื ื™ื™ื

ืฉืคืœื”, ื“ืจื•ื

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-698

ืื™ืฉ.ืช ืชื•ื›ืŸ ื•ืงืจื™ืื™ื™ื˜ื™ื‘ ืœืžื—ืœืงืช ืฉื™ื•ื•ืง

ืžืจื›ื–

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-695

ืื™ืฉ/ืช ืžื›ื™ืจื•ืช ืœื—ื˜ื™ื‘ืช ืžื›ืฉื•ืจ ื›ืจื•ืจื’ื™ื” ืžืจื›ื–

ืžืจื›ื–

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-747

ืžื”ื ื“ืก/ืช ืจื’ื•ืœืฆื™ื” ื‘ื—ื‘ืจืช ืžื›ืฉื•ืจ ืจืคื•ืื™ ื‘ืงื™ืกืจื™ื”

ืฆืคื•ืŸ, ืฉืจื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-692

ืžื”ื ื“ืก.ืช ื•ืœื™ื“ืฆื™ื” ืžื›ืฉื•ืจ ืจืคื•ืื™ ื‘ืฆืคื•ืŸ

ืฆืคื•ืŸ, ืฉืจื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-693

ืžื”ื ื“ืก. ืื™ื›ื•ืช ืœื—ื‘ืจืช ืžื›ืฉื•ืจ ืจืคื•ืื™ ื‘ืงื™ืกืจื™ื”

ืฆืคื•ืŸ, ืฉืจื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-729

ืžื”ื ื“ืก.ืช ืฉื™ืจื•ืช ืชื—ื•ื ืžื›ืฉื•ืจ ืจืคื•ืื™ ืžืขื‘ื“ืชื™

ืฉืคืœื”, ืžืจื›ื–, ืฉืจื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-689

ืจื›ื–/ืช ื’ื™ื•ืก ืœื—ื‘ืจื” ื‘ืื–ื•ืจ ื”ืžืจื›ื–

ืžืจื›ื–

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-686

ืื™ืฉ /ืืฉืช ืืคืœื™ืงืฆื™ื” ืœืžื—ืœืงืช ื”ื’ื ื˜ื™ืงื”

ื›ืœ ื”ืืจืฅ, ื“ืจื•ื, ืžืจื›ื–, ืฆืคื•ืŸ, ืฉืคืœื”, ืฉืจื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-665

ื ืฆื™ื’/ืช ืžื›ื™ืจื•ืช ืœืžื—ืœืงืช ืžื›ืฉื•ืจ ื•ืžืชื›ืœื™ื ืœืžืขื‘ื“ื•ืช ืžื—ืงืจ

ืžืจื›ื–

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-664

ื ืฆื™ื’.ืช ืžื›ื™ืจื•ืช ืืกื˜ื˜ื™ืงื” ืื–ื•ืจ ื™ืจื•ืฉืœื™ื-ื“ืจื•ื

ื“ืจื•ื, ืฉืคืœื”

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-661

ืื™ืฉ/ืช ืžื›ื™ืจื•ืช ืœื—ื˜ื™ื‘ืช ืžื›ืฉื•ืจ ื›ืจื•ืจื’ื™ื” ืฆืคื•ืŸ

ืฆืคื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-645

QA&RA Manager Medical device company

ืฉืจื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-598

ืžื•ืžื—ื”/ื™ืช ืžื›ื™ืจื•ืช ืœืชื—ื•ื ืžื›ืฉื•ืจ ืœื™ื™ื–ืจ ืขื™ื ื™ื™ื

ื›ืœ ื”ืืจืฅ, ืžืจื›ื–, ืฉืคืœื”, ืฉืจื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-581

ืื™ืฉ.ืช ืžื›ื™ืจื•ืช ื™ืจื•ืฉืœื™ื ื•ื“ืจื•ื ืžื•ืฆืจื™ ืžื—ืงืจ ื‘ื™ื•ืœื•ื’ื™ื™ื

ืฉืคืœื”, ื“ืจื•ื, ืžืจื›ื–

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-556

ื ืฆื™ื’/ืช ืžื›ื™ืจื•ืช ืจืคื•ืื™ ืœื—ื‘ืจืช ืžื›ืฉื•ืจ ืจืคื•ืื™

ืžืจื›ื–, ื“ืจื•ื, ืฉืจื•ืŸ, ืฉืคืœื”, ืฆืคื•ืŸ, ื›ืœ ื”ืืจืฅ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-456

ืื™ืฉ/ืช ืžื›ื™ืจื•ืช ืฉื˜ื— ืœื—ื‘ืจืช ืžื™ื›ืฉื•ืจ ืจืคื•ืื™

ืžืจื›ื–, ืฉืจื•ืŸ, ืฉืคืœื”

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-436

ืžื ื”ืœ.ืช ื—ืฉื‘ื•ื ื•ืช ืœื—ื‘ืจื” ื™ื‘ื•ืื ื™ืช ื‘ืชื—ื•ื ื”ืžื›ืฉื•ืจ ืจืคื•ืื™ ื•ืคืืจืžื”

ืฉืจื•ืŸ

ืื™ื–ื•ืจ:

ืžืœืื”

ื”ื™ืงืฃ:

JB-455

ื ื›ื•ืŸ ืœืขื›ืฉื™ื• ืœื ืงื™ื™ืžื•ืช ืžืฉืจื•ืช ืœืคื™ ื”ืกื™ื ื•ืŸ ื”ืžื‘ื•ืงืฉ.

ื ืกื” ืกื™ื ื•ืŸ ื—ื“ืฉ ืื• ื‘ื—ืจ ืชื—ื•ื ืื—ืจ.

ืžืฉืจื•ืช ื“ืจื•ืฉื™ื ืžื›ืฉื•ืจ ืจืคื•ืื™

ื—ื‘ืจืช DH-R ื”ื™ื ืœื ืจืง ืคืœื˜ืคื•ืจืžื” ืœื—ื™ืคื•ืฉ ื“ืจื•ืฉื™ื ื•ืžืฉืจื•ืช ืžื›ืฉื•ืจ ืจืคื•ืื™, ืืœื ื’ื ืฉื•ืชืฃ ืžื”ื•ืชื™ ื‘ื‘ื ื™ื™ืช ื”ืขืชื™ื“ ืฉืœ ืขื ืฃ ื”ืจืคื•ืื”. ื‘ืืžืฆืขื•ืช ื”ืคืœื˜ืคื•ืจืžื” ืฉืœื ื• ื•ื‘ืฉื™ืชื•ืฃ ืฆื•ื•ืช ืžื™ื•ืžืŸ ืฉืœ ืžื•ืžื—ื™ื, ืื ื• ืžืฆืœื™ื—ื™ื ืœืกืคืง ืœืœืงื•ื—ื•ืชื™ื ื• ืืช ื”ื›ืœื™ื ื”ื ื“ืจืฉื™ื ืœืžืฆื™ืืช ื”ืขื‘ื•ื“ื” ื”ืžื•ืฉืœืžืช ืขื‘ื•ืจื. ืื ื• ืžืฆื™ืขื™ื ืžื’ื•ื•ืŸ ืจื—ื‘ ืฉืœ ืžืฉืจื•ืช ื‘ื—ื‘ืจื•ืช ืžื›ืฉื•ืจ ืจืคื•ืื™, ืชื•ืš ืฉื™ืžืช ื“ื’ืฉ ืขืœ ื”ืชืืžื” ืžื“ื•ื™ืงืช ืฉืœ ื›ื™ืฉื•ืจื™ ื”ืžื•ืขืžื“ื™ื ืœื“ืจื™ืฉื•ืช ื”ืชืคืงื™ื“ื™ื ื”ืžื™ื•ื—ื“ื™ื ื‘ืขื ืฃ ื–ื”, ื•ืžื‘ื˜ื™ื—ื™ื ื—ื•ื•ื™ืช ื—ื™ืคื•ืฉ ืขื‘ื•ื“ื” ืžืงืฆื•ืขื™ืช ื•ื™ืขื™ืœื”.


ื‘ืžืื” ื”-21, ืขื ื”ืชืคืชื—ื•ืช ื˜ื›ื ื•ืœื•ื’ื™ืช ืžืชืžื“ืช, ืชื—ื•ื ื”ืจืคื•ืื” ื•ืžื›ืฉื•ืจ ืจืคื•ืื™ ื ืžืฆืื™ื ื‘ืชื”ืœื™ืš ืฉืœ ืฉื™ื ื•ื™ ื•ืฉื™ืคื•ืจ ืจืฆื™ื ื™. ืžื›ืฉื•ืจ ืจืคื•ืื™ ืžืชืงื“ื ืžืืคืฉืจ ืœืจื•ืคืื™ื ื•ืœืžื˜ืคืœื™ื ืœื‘ืฆืข ืคืจื•ืฆื“ื•ืจื•ืช ืจืคื•ืื™ื•ืช ื‘ื“ื™ื•ืง ื’ื‘ื•ื” ื•ื‘ื™ืขื™ืœื•ืช ืžื•ื’ื‘ืจืช, ื•ื”ื•ื ืžื”ื•ื•ื” ืืช ื”ื™ืกื•ื“ ื”ื‘ืกื™ืกื™ ืฉืœ ืชื—ื•ื ื”ืจืคื•ืื” ื”ืขื›ืฉื•ื•ื™. ื›ืชื•ืฆืื” ืžื›ืš, ืฆืฆื•ืช ืžืฉืจื•ืช ืจื‘ื•ืช ื‘ืชื—ื•ื, ื•ื”ื‘ื™ืงื•ืฉ ืœืžื•ืขืžื“ื™ื ื‘ืชื—ื•ื ื–ื” ืจืง ื”ื•ืœืš ื•ื’ื•ื‘ืจ. ื‘-DH-R, ืื ื• ืžืฆื™ืขื™ื ืžื’ื•ื•ืŸ ืจื—ื‘ ืฉืœ ืžืฉืจื•ืช ื“ืจื•ืฉื™ื ืžื›ืฉื•ืจ ืจืคื•ืื™, ื›ื•ืœืœ ืžืฉืจื•ืช ืœืื ืฉื™ ืžื›ื™ืจื•ืช ื•ืžื”ื ื“ืกื™ื ื‘ืชื—ื•ื.


DH-R :ื”ื“ืจืš ืฉืœืš ืœืžืฉืจื•ืช ืžื›ืฉื•ืจ ืจืคื•ืื™

ื‘-DH-R, ืื ื• ืžื—ื•ื™ื‘ื™ื ืœื”ื‘ื˜ื™ื— ืฉื›ืœ ืžื™ ืฉืžืขื•ื ื™ื™ืŸ ืœืงื—ืช ื—ืœืง ื‘ืชื—ื•ื ื”ืžื›ืฉื•ืจ ื”ืจืคื•ืื™ ื™ืžืฆื ืืช ื”ื”ื–ื“ืžื ื•ืช ื”ืžืชืื™ืžื” ืœื•. ืื ื• ืžืฆื™ืขื™ื ืžืฉืจื•ืช ืžื›ืฉื•ืจ ืจืคื•ืื™ ื‘ื›ืœ ืจืžื•ืช ื”ื ื™ืกื™ื•ืŸ, ื•ืžื’ื•ื•ืŸ ืจื—ื‘ ืฉืœ ืžืฉืจื•ืช ื‘ื—ื‘ืจื•ืช ืžื›ืฉื•ืจ ืจืคื•ืื™, ื›ื’ื•ืŸ ืžืฉืจื•ืช ืžื”ื ื“ืกื™ ืฉื™ืจื•ืช, ืื ืฉื™ ืžื›ื™ืจื•ืช, ื•ืžืฉืจื•ืช ืื‘ื˜ื—ืช ืื™ื›ื•ืช. ื—ื™ืคื•ืฉ ืžื•ื“ืขื•ืช ื“ืจื•ืฉื™ื ื‘ืžื›ืฉื•ืจ ืจืคื•ืื™ ื‘ืืžืฆืขื•ืช DH-R ืžืืคืฉืจ ืœื›ืœ ืžื•ืขืžื“ ืœื”ืฉืชืœื‘ ื‘ืชื—ื•ื ืžืชืคืชื— ื•ืžืืชื’ืจ, ืขื ื”ื–ื“ืžื ื•ื™ื•ืช ืจื‘ื•ืช ืœืฆืžื•ื— ื•ืœื”ืฉืคื™ืข. ื›ื“ื™ ืœื”ื‘ื™ืŸ ืืช ืžื’ื•ื•ืŸ ื”ืžืฉืจื•ืช ื‘ืžื›ืฉื•ืจ ืจืคื•ืื™ ื”ืงื™ื™ืžื•ืช, ื—ืฉื•ื‘ ืœื”ื‘ื™ืŸ ืืช ืžืกืข ื”ื—ื™ื™ื ืฉืœ ืžื›ืฉื™ืจ ืจืคื•ืื™, ืžืจืขื™ื•ืŸ ื•ืขื“ ืœืžื˜ื•ืคืœ. ื›ืœ ืฉืœื‘ ื‘ืžืกืข ื”ื–ื” ื“ื•ืจืฉ ืื ืฉื™ ืžืงืฆื•ืข ืขื ื›ื™ืฉื•ืจื™ื ืฉื•ื ื™ื:


  • ืฉืœื‘ ื”ืžื—ืงืจ ื•ื”ืคื™ืชื•ื— (R&D): ื›ืืŸ ื”ื›ืœ ืžืชื—ื™ืœ. ืžื”ื ื“ืกื™ื, ืžื“ืขื ื™ื ื•ืžืคืชื—ื™ื ื”ื•ืคื›ื™ื ืจืขื™ื•ืŸ ืžื“ืขื™ ืื• ืฆื•ืจืš ืงืœื™ื ื™ ืœืงื•ื ืกืคื˜ ื˜ื›ื ื•ืœื•ื’ื™. ืฉืœื‘ ื–ื” ื›ื•ืœืœ ืชื›ื ื•ืŸ, ื‘ื ื™ื™ืช ืื‘ื•ืช ื˜ื™ืคื•ืก, ื•ืื™ื ืกื•ืฃ ื‘ื“ื™ืงื•ืช.

  • ื”ืฉืœื‘ ื”ืงืœื™ื ื™ ื•ื”ืจื’ื•ืœื˜ื•ืจื™: ืœืคื ื™ ืฉืžื•ืฆืจ ื™ื›ื•ืœ ืœื”ื’ื™ืข ืœืฉื•ืง, ื”ื•ื ื—ื™ื™ื‘ ืœื”ื•ื›ื™ื— ืืช ื‘ื˜ื™ื—ื•ืชื• ื•ื™ืขื™ืœื•ืชื• ื‘ื ื™ืกื•ื™ื™ื ืงืœื™ื ื™ื™ื ื•ืœืงื‘ืœ ืื™ืฉื•ืจ ืžืจืฉื•ื™ื•ืช ืจื’ื•ืœื˜ื•ืจื™ื•ืช ื›ืžื• ื”-FDA ื”ืืžืจื™ืงืื™ ืื• ื”-CE ื”ืื™ืจื•ืคื™. ื–ื”ื• ืฉืœื‘ ืงืจื™ื˜ื™ ื”ื“ื•ืจืฉ ื“ื™ื•ืง ื•ืชืฉื•ืžืช ืœื‘ ืžืจื‘ื™ืช ืœืคืจื˜ื™ื.

  • ืฉืœื‘ ื”ืื™ื›ื•ืช ื•ื”ื™ื™ืฆื•ืจ: ืœืื—ืจ ืงื‘ืœืช ื”ืื™ืฉื•ืจื™ื, ื”ืžื›ืฉื™ืจ ืขื•ื‘ืจ ืœื™ื™ืฆื•ืจ ื”ืžื•ื ื™. ืฉืœื‘ ื–ื” ืžืคื•ืงื— ื‘ืงืคื“ื ื•ืช ืขืœ ื™ื“ื™ ืื ืฉื™ ื”ื‘ื˜ื—ืช ืื™ื›ื•ืช (QA) ื•ื‘ืงืจืช ืื™ื›ื•ืช (QC) ื›ื“ื™ ืœื”ื‘ื˜ื™ื— ืฉื›ืœ ืžื›ืฉื™ืจ ื”ื™ื•ืฆื ืžื”ืžืคืขืœ ืขื•ืžื“ ื‘ืกื˜ื ื“ืจื˜ื™ื ื”ื’ื‘ื•ื”ื™ื ื‘ื™ื•ืชืจ.

  • ื”ืฉืœื‘ ื”ืžืกื—ืจื™ โ€“ ืฉื™ื•ื•ืง ื•ืžื›ื™ืจื•ืช: ื–ื”ื• ื”ืฉืœื‘ ืฉื‘ื• ื”ืžื•ืฆืจ ืคื•ื’ืฉ ืืช ื”ืฉื•ืง. ืื ืฉื™ ืฉื™ื•ื•ืง ื‘ื•ื ื™ื ืืช ื”ืกื™ืคื•ืจ ืฉืœ ื”ืžื•ืฆืจ, ื•ืื ืฉื™ ืžื›ื™ืจื•ืช ืžืฆื™ื’ื™ื ืื•ืชื• ืœืจื•ืคืื™ื, ื‘ืชื™ ื—ื•ืœื™ื ื•ืžืคื™ืฆื™ื.

  • ืฉืœื‘ ื”ืชืžื™ื›ื” ืœืื—ืจ ื”ืฉื™ื•ื•ืง: ื’ื ืœืื—ืจ ืฉื”ืžื›ืฉื™ืจ ื ืžื›ืจ, ื ื“ืจืฉืช ืชืžื™ื›ื” ืžืชืžื“ืช ื‘ืžืฉืชืžืฉื™ื, ื”ื“ืจื›ื•ืช, ื•ืื™ืกื•ืฃ ื ืชื•ื ื™ื ืžื”ืฉื˜ื— ืœืฆื•ืจืš ืฉื™ืคื•ืจ ื”ื“ื•ืจ ื”ื‘ื ืฉืœ ื”ืžื•ืฆืจื™ื.


ืžืคืช ื”ืชืคืงื™ื“ื™ื: ืื™ืคื” ื”ืžืงื•ื ืฉืœื›ื ื‘ืชืขืฉื™ื™ื”?

ื”ื‘ื ืช ืฉืจืฉืจืช ื”ืขืจืš ืžืืคืฉืจืช ืœื ื• ืœืžืคื•ืช ืืช ืชืคืงื™ื“ื™ ื”ืžืคืชื—. ื”ื ื” ืกืงื™ืจื” ืฉืœ ื›ืžื” ืžื”ืชืคืงื™ื“ื™ื ื”ืžื‘ื•ืงืฉื™ื ื‘ื™ื•ืชืจ ืฉืื ื• ืžื’ื™ื™ืกื™ื ืืœื™ื”ื:

ืชืคืงื™ื“ื™ ืžื—ืงืจ ื•ืคื™ืชื•ื— (R&D)
  • ืžื”ื ื“ืก/ืช ืžื›ื•ื ื•ืช / ื—ื•ืžืจื”: ืื—ืจืื™ื ืขืœ ื”ืชื›ื ื•ืŸ ื”ืžื›ืื ื™ ื•ื”ืคื™ื–ื™ ืฉืœ ื”ืžื›ืฉื™ืจ, ื‘ื—ื™ืจืช ื—ื•ืžืจื™ื, ื•ื‘ื ื™ื™ืช ืื‘ื•ืช ื˜ื™ืคื•ืก.

  • ืžื”ื ื“ืก/ืช ืชื•ื›ื ื” / ืืœื’ื•ืจื™ืชืžื™ื: ืžืคืชื—ื™ื ืืช ื”ืชื•ื›ื ื” ืฉืžืคืขื™ืœื” ืืช ื”ืžื›ืฉื™ืจ, ืืช ื”ืืœื’ื•ืจื™ืชืžื™ื ื”ืžื ืชื—ื™ื ืืช ื”ื ืชื•ื ื™ื, ื•ืืช ื”ืžืžืฉืง ืœืžืฉืชืžืฉ.

  • ืžื”ื ื“ืก/ืช ืžืขืจื›ืช: ื”"ืื™ื ื˜ื’ืจื˜ื•ืจ" ืฉืจื•ืื” ืืช ื”ืชืžื•ื ื” ื”ื’ื“ื•ืœื”, ื•ืื—ืจืื™ ืขืœ ืฉื™ืœื•ื‘ ื›ืœ ืจื›ื™ื‘ื™ ื”ืžืขืจื›ืช (ื—ื•ืžืจื”, ืชื•ื›ื ื”, ื‘ื™ื•ืœื•ื’ื™ื”) ืœื›ื“ื™ ืžื•ืฆืจ ืื—ื“ ืฉืขื•ื‘ื“.


ืชืคืงื™ื“ื™ ืื™ื›ื•ืช ื•ืจื’ื•ืœืฆื™ื” (QA/RA)
  • ืื™ืฉ/ืืฉืช ืจื’ื•ืœืฆื™ื” (RA Specialist): ื”ืžื•ืžื—ื” ืœื‘ื™ืจื•ืงืจื˜ื™ื” ื”ืจืคื•ืื™ืช. ืื—ืจืื™ ืขืœ ื”ื›ื ืช ื”ืชื™ืงื™ื ืœื”ื’ืฉื” ืœืจืฉื•ื™ื•ืช ื”ื‘ืจื™ืื•ืช (FDA, CE), ื•ืขืœ ื”ื‘ื˜ื—ืช ืขืžื™ื“ืช ื”ื—ื‘ืจื” ื‘ื›ืœ ื”ืชืงื ื™ื ื•ื”ื“ืจื™ืฉื•ืช ื”ืจื’ื•ืœื˜ื•ืจื™ื•ืช.

  • ืžื”ื ื“ืก/ืช ื”ื‘ื˜ื—ืช ืื™ื›ื•ืช (QA Engineer): ืื—ืจืื™ ืขืœ ื‘ื ื™ื™ืช ื•ืชื—ื–ื•ืงืช ืžืขืจื›ืช ื”ืื™ื›ื•ืช ืฉืœ ื”ื—ื‘ืจื”, ื›ืชื™ื‘ืช ื ื”ืœื™ื, ื•ื‘ื™ืฆื•ืข ื‘ื™ืงื•ืจื•ืช ืคื ื™ืžื™ื•ืช ื•ื—ื™ืฆื•ื ื™ื•ืช, ื‘ื”ืชืื ืœืชืงื ื™ื ื›ืžื• ISO 13485.


ืชืคืงื™ื“ื™ื ืงืœื™ื ื™ื™ื
  • ืžื•ื‘ื™ืœ/ืช ืžื—ืงืจ ืงืœื™ื ื™ (CRA - Clinical Research Associate): ืžื ื”ืœ ืืช ื”ื ื™ืกื•ื™ื™ื ื”ืงืœื™ื ื™ื™ื ื‘ื‘ืชื™ ื”ื—ื•ืœื™ื, ืžื•ื•ื“ื ืฉื”ื ืžืชื ื”ืœื™ื ืœืคื™ ื”ืคืจื•ื˜ื•ืงื•ืœ, ื•ืื—ืจืื™ ืขืœ ืื™ืกื•ืฃ ื•ืื™ืžื•ืช ื”ื ืชื•ื ื™ื ื”ืžื•ื›ื™ื—ื™ื ืืช ื™ืขื™ืœื•ืช ื•ื‘ื˜ื™ื—ื•ืช ื”ืžื•ืฆืจ.

  • ืžื•ืžื—ื”/ื™ืช ื™ื™ืฉื•ืžื™ื ืงืœื™ื ื™ื™ื (Clinical Application Specialist): ื”ื’ืฉืจ ื‘ื™ืŸ ื”ืžื•ืฆืจ ืœื‘ื™ืŸ ื”ืžืฉืชืžืฉ ื”ืกื•ืคื™. ืชืคืงื™ื“ื ื”ื•ื ืœื”ื“ืจื™ืš ืจื•ืคืื™ื ื•ืื—ื™ื•ืช ื›ื™ืฆื“ ืœื”ืฉืชืžืฉ ื ื›ื•ืŸ ื‘ืžื›ืฉื™ืจ, ืœืชืžื•ืš ื‘ื”ื ื‘ืžื”ืœืš ืคืจื•ืฆื“ื•ืจื•ืช, ื•ืœื”ืขื‘ื™ืจ ืžืฉื•ื‘ ืžื”ืฉื˜ื— ื—ื–ืจื” ืœืžื—ืœืงืช ื”ืคื™ืชื•ื—.


ืชืคืงื™ื“ื™ื ืžืกื—ืจื™ื™ื
  • ืื™ืฉ/ืืฉืช ืžื›ื™ืจื•ืช ืžื›ืฉื•ืจ ืจืคื•ืื™: ืชืคืงื™ื“ ืžืืชื’ืจ ื”ื“ื•ืจืฉ ื”ื‘ื ื” ื˜ื›ื ื™ืช ืฉืœ ื”ืžื•ืฆืจ, ื™ื›ื•ืœืช ืœื‘ื ื•ืช ืงืฉืจื™ื ืขื ืฆื•ื•ืชื™ื ืจืคื•ืื™ื™ื, ื•ืœื ื”ืœ ืชื”ืœื™ื›ื™ ืžื›ื™ืจื” ืžื•ืจื›ื‘ื™ื ื‘ื‘ืชื™ ื—ื•ืœื™ื ื•ื‘ืžืจืคืื•ืช.

  • ืžื ื”ืœ/ืช ืžื•ืฆืจ / ืฉื™ื•ื•ืง: ืื—ืจืื™ื ืขืœ ื‘ื ื™ื™ืช ื”ืืกื˜ืจื˜ื’ื™ื” ื”ืฉื™ื•ื•ืงื™ืช, ื ื™ืชื•ื— ื”ืฉื•ืง ื•ื”ืžืชื—ืจื™ื, ืคื™ืชื•ื— ื—ื•ืžืจื™ื ืฉื™ื•ื•ืงื™ื™ื, ื•ื”ืฉืงืช ื”ืžื•ืฆืจ ืœืฉื•ื•ืงื™ื ื—ื“ืฉื™ื.


ื”-DNA ื”ื ื“ืจืฉ ืœื”ืฆืœื—ื”: ื”ื›ื™ืฉื•ืจื™ื ืฉื”ื—ื‘ืจื•ืช ื”ืžื•ื‘ื™ืœื•ืช ืžื—ืคืฉื•ืช

ืžืขื‘ืจ ืœืชื•ืืจ ื”ืจืœื•ื•ื ื˜ื™ (ื‘ื”ื ื“ืกื”, ืžื“ืขื™ ื”ื—ื™ื™ื ื•ื›ื•'), ื”ืฆืœื—ื” ื‘ืชืขืฉื™ื™ืช ื”ืžื›ืฉื•ืจ ื”ืจืคื•ืื™ ื“ื•ืจืฉืช ืฉื™ืœื•ื‘ ื™ื™ื—ื•ื“ื™ ืฉืœ ื›ื™ืฉื•ืจื™ื:

  • ื“ื™ื•ืง ื•ืชืฉื•ืžืช ืœื‘ ืื•ื‘ืกืกื™ื‘ื™ืช ืœืคืจื˜ื™ื: ื‘ืชืขืฉื™ื™ื” ืฉื‘ื” ื˜ืขื•ืช ืงื˜ื ื” ืขืœื•ืœื” ืœืขืœื•ืช ื‘ื—ื™ื™ ืื“ื, ืื™ืŸ ืžืงื•ื ืœืขื™ื’ื•ืœ ืคื™ื ื•ืช.

  • ื™ื›ื•ืœืช ืœืžื™ื“ื” ื’ื‘ื•ื”ื”: ื”ื˜ื›ื ื•ืœื•ื’ื™ื” ื•ื”ื“ืจื™ืฉื•ืช ื”ืจื’ื•ืœื˜ื•ืจื™ื•ืช ืžืฉืชื ื•ืช ืœืœื ื”ืจืฃ, ื•ื—ื•ื‘ื” ืœื”ื™ืฉืืจ ืชืžื™ื“ ืžืขื•ื“ื›ื ื™ื.

  • ืชืงืฉื•ืจืช ื‘ื™ื ืื™ืฉื™ืช ืžืขื•ืœื”: ื›ืžืขื˜ ื›ืœ ืชืคืงื™ื“ ื“ื•ืจืฉ ืขื‘ื•ื“ื” ื‘ืฆื•ื•ืชื™ื ืจื‘-ืชื—ื•ืžื™ื™ื (ืžื”ื ื“ืกื™ื, ืจื•ืคืื™ื, ืื ืฉื™ ืฉื™ื•ื•ืง) ื•ื”ื™ื›ื•ืœืช ืœืชืงืฉืจ ื‘ื™ืขื™ืœื•ืช ื”ื™ื ืงืจื™ื˜ื™ืช.

  • ืื ื’ืœื™ืช ื‘ืจืžื” ื’ื‘ื•ื”ื”: ื–ื•ื”ื™ ื”ืฉืคื” ื”ืจืฉืžื™ืช ืฉืœ ื”ืชืขืฉื™ื™ื” ื”ื’ืœื•ื‘ืœื™ืช, ื•ื”ื™ื ื—ื™ื•ื ื™ืช ืœืงืจื™ืืช ืžืืžืจื™ื, ืœืขื‘ื•ื“ื” ืžื•ืœ ืจืฉื•ื™ื•ืช ื‘ื™ื ืœืื•ืžื™ื•ืช ื•ืœืชืงืฉื•ืจืช ืขื ืœืงื•ื—ื•ืช ื•ืฉื•ืชืคื™ื ื‘ื—ื•"ืœ.


ืœืžื” ืœืขื‘ื•ื“ ืขื ื—ื‘ืจืช ื”ืฉืžื” ื”ืžืชืžื—ื” ื‘ืžืฉืจื•ืช ืžื›ืฉื•ืจ ืจืคื•ืื™?

ื‘ืขื•ื“ ืฉื ื™ืชืŸ ืœื—ืคืฉ ืžืฉืจื•ืช ื‘ืื•ืคืŸ ืขืฆืžืื™, ืขื‘ื•ื“ื” ืขื ื—ื‘ืจืช ื”ืฉืžื” ื‘ื•ื˜ื™ืงื™ืช ื•ืžืชืžื—ื” ื›ืžื• D-HR ืžืขื ื™ืงื” ืœื›ื ื™ืชืจื•ืŸ ืชื—ืจื•ืชื™ ืขืฆื•ื. ืื ื• ืœื ืจืง "ืžืขื‘ื™ืจื™ื ืงื•ืจื•ืช ื—ื™ื™ื"; ืื ื• ืฉื•ืชืคื™ื ืืกื˜ืจื˜ื’ื™ื™ื ืœืงืจื™ื™ืจื” ืฉืœื›ื.

  • ืื ื• ืžื“ื‘ืจื™ื ืืช ื”ืฉืคื”: ืื ื• ืžื‘ื™ื ื™ื ืืช ื”ื”ื‘ื“ืœ ื”ื“ืง ื‘ื™ืŸ QA ืœ-QC, ื‘ื™ืŸ RA ืœ-CRA. ืื ื• ื™ื•ื“ืขื™ื ืœื–ื”ื•ืช ืืช ื”ื›ื™ืฉื•ืจื™ื ื”ื™ื™ื—ื•ื“ื™ื™ื ืฉืœื›ื ื•ืœื”ืชืื™ื ืœื›ื ืืช ื”ืชืคืงื™ื“ ื”ืžื“ื•ื™ืง.

  • ื’ื™ืฉื” ืœื”ื–ื“ืžื ื•ื™ื•ืช ื‘ืœืขื“ื™ื•ืช: ื—ื‘ืจื•ืช ื”ืžื“-ื˜ืง ื”ืžื•ื‘ื™ืœื•ืช ื‘ื™ืฉืจืืœ ืกื•ืžื›ื•ืช ืขืœ ื”ืžื•ืžื—ื™ื•ืช ืฉืœื ื• ื•ืขืœ ื”ื™ื›ื•ืœืช ืฉืœื ื• ืœืืชืจ ืขื‘ื•ืจืŸ ืืช ื”ืžื•ืขืžื“ื™ื ื”ื˜ื•ื‘ื™ื ื‘ื™ื•ืชืจ. ืจื‘ื•ืช ืžื”ืžืฉืจื•ืช ืฉืื ื• ืžื˜ืคืœื™ื ื‘ื”ืŸ ื”ืŸ ื‘ืœืขื“ื™ื•ืช ื•ืœื ืžืชืคืจืกืžื•ืช ื‘ืฆื™ื‘ื•ืจ.

  • ืœื™ื•ื•ื™ ื•ื™ื™ืขื•ืฅ ืงืจื™ื™ืจื”: ื‘ื–ื›ื•ืช ื”ื”ื™ื›ืจื•ืช ื”ืขืžื•ืงื” ืฉืœื ื• ืขื ื”ืชืขืฉื™ื™ื”, ื ื•ื›ืœ ืœื™ื™ืขืฅ ืœื›ื ืขืœ ืžืกืœื•ืœื™ ืงืจื™ื™ืจื” ืืคืฉืจื™ื™ื, ืœืขื–ื•ืจ ืœื›ื ืœืžืงื“ ืืช ื”ื—ื™ืคื•ืฉ, ื•ืœื”ื›ื™ืŸ ืืชื›ื ื‘ืฆื•ืจื” ื”ื˜ื•ื‘ื” ื‘ื™ื•ืชืจ ืœืจืื™ื•ื ื•ืช ืขื‘ื•ื“ื”.


ืชืขืฉื™ื™ืช ื”ืžื›ืฉื•ืจ ื”ืจืคื•ืื™ ื‘ื™ืฉืจืืœ ื”ื™ื ืžื”ืžื•ื‘ื™ืœื•ืช ื‘ืขื•ืœื, ื•ื”ื™ื ืžื—ื›ื” ืœืื ืฉื™ื ื”ืžื‘ืจื™ืงื™ื, ื”ืžื“ื•ื™ืงื™ื ื•ื”ืžื•ื›ืฉืจื™ื ื‘ื™ื•ืชืจ, ืฉืจื•ืฆื™ื ืœืฉืœื‘ ื‘ื™ืŸ ืืชื’ืจ ื˜ื›ื ื•ืœื•ื’ื™ ืœืžืฉืžืขื•ืช.


ืื ื™ืฉ ืœื›ื ืืช ื”ืชืฉื•ืงื” ืœื—ื“ืฉื ื•ืช, ืืช ื”ืจืฆื•ืŸ ืœื”ืฉืคื™ืข, ื•ืืช ื”ืžืงืฆื•ืขื™ื•ืช ื”ื ื“ืจืฉืช, D-HR ื”ื™ื ื”ื’ืฉืจ ืฉืœื›ื ืœื”ื–ื“ืžื ื•ืช ื”ื‘ืื”. ืื ื• ืžื–ืžื™ื ื™ื ืืชื›ื ืœืขื™ื™ืŸ ื‘ืžื’ื•ื•ืŸ ืžืฉืจื•ืช ืžื›ืฉื•ืจ ืจืคื•ืื™ ื”ืคืชื•ื—ื•ืช ืฉืœื ื•, ืœืฉืœื•ื— ืงื•ืจื•ืช ื—ื™ื™ื, ื•ืœืชืช ืœืžื•ืžื—ื™ื•ืช ืฉืœ ื“ืคื ื” ื•ืฆื•ื•ืช D-HR ืœืคืชื•ื— ืœื›ื ืืช ื”ื“ืœืช ืœืงืจื™ื™ืจื” ื”ื‘ืื” ืฉืœื›ื.


ืžืฉืจื•ืช ื ื•ืกืคื•ืช

bottom of page